Aurora refuses offer of $5/week, conflicts with currif
The Board of Directors of Aurora Cannervis ($ ACB) has again advised shareholders to reject the proposed amendment to $ Cura · $ CURLF.
This article may contain affiliate links. Commercial relationships are disclosed in the affiliate policy.
What happened
The Board of Directors of Aurora Cannervis ($ ACB) has again advised shareholders to reject the proposed amendment to $ Cura · $ CURLF. The offer is conditional on the offering of 0.4013 shares of Currariff stock and $1 in cash per share of Aurora stock. Aurora reaffirmed its position following the unanimous recommendation of the Independent Special Committee on October 14. The shareholders were advised not to respond to the offer to sell the shares immediately. The offer expires on December 4, 2026. Currariff offered a total value of $5 per share at its closing price on October 2. The maximum cost limit was raised from $5 to $6. $5 does not represent a fixed cash payout because it includes the price of the stock, and the actual value depends on the price of the curriff stock… Load more
Reported details
No additional source details were retained.
Why this matters
Aurora is a factual update rather than a structural change to tokenized assets. Its value to a desk is the sourced detail and the timing, so read it next to the linked reporting and treat any figure the sources do not state as unknown.
Evidence boundary
The scope is limited to what the linked reports state, and where two of them diverge both positions are recorded without either being picked in advance.
What to verify
Corroborate Aurora with one independent dated source, and treat any figure the linked reports do not state as unknown rather than inferred.
Sources and editorial check time
-
TokenPost RSS: https://www.tokenpost.kr/news/market/422665
-
CoinPost RSS: https://coinpost.jp/?p=743045
-
Editorial source check time: 2026-10-15T04:16:18.897Z
This information is educational and is not financial, legal, or tax advice.